Browse studies

Find your next paid study

4 recruiting studies matching your filters

A Phase II Study to Evaluate the Use of the MEK Inhibitor Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults

Background: Large and giant congenital melanocytic nevi (LGCMN) are dark birthmarks (moles). They can grow to 8 inches or more across. People with LGCMN have …

LGCMNLarge and Giant Congenital Melanocytic NeviNF1+8 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07891286

Phase 3

Pragmatic Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) (AI)

The purpose of this study is to learn whether a computer-based support tool called DEXI (Dermoscopy EXplainable Intelligence) can help dermatologists decide wh…

Malignant Melanoma of SkinOther and Unspecified Malignant Neoplasm of SkinMelanoma in Situ+13 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Genetic Basis of Melanocytic Nevi

The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be pe…

Melanocytic Nevi

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, DavisNCT03054584

Prospective Registry of Patients With Neurocutaneous Melanocytosis (NCM) Including Cutaneous and CNS Involvement

This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanoc…

Cutaneous Melanocytic NeoplasmLarge Cutaneous Melanocytic NeviNeurocutaneous Melanocytosis

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT04548817